Global Liquid Biopsy Market By Product Type (Instruments, Consumables Kits and Reagents, Software and Services) By Biomarker Type (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Extracellular Vesicles (EVs), Other Biomarker Types) By Technology (Multi-gene-parallel Analysis (NGS) and Single Gene Analysis (PCR Microarrays)) by Application (Cancer, Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Gastrointestinal Cancer, Reproductive Health and Other Applications) By End-use (Hospitals and Laboratories, Specialty Clinics, Academic and Research Centers Other End-Uses) By Clinical Application (Therapy Selection, Treatment Monitoring, Early Cancer Screening, Recurrence Monitoring and Other Clinical Applications) and forecast 2024-2033
Report Overview The global liquid biopsy market size is expected to be worth around USD 35.3 billion by 2033, from USD 10.3 billion in 2023, growing at a CAGR of 13.1% during the for...
